Health
New tool can provide non-invasive decision support for NSCLC treatment – News-Medical.net
Personalized treatment options for patients with lung cancer have come a long way in the past two decades.
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
Personalized treatment options for patients with lung cancer have come a long way in the past two decades. For patients with non-small cell lung cancer, the most common subtype of lung cancer and the leading cause of cancer-related death worldwide, two major treatment strategies have emerged: tyrosine kinase inhibitors and immune checkpoint inhibitors. However, choosing the right therapy for a non-small cell lung cancer patient isn’t always an easy …
-
Noosa News11 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business16 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business16 hours agoWhere will Nvidia stock be in 1 year?
-
General15 hours agoAboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts